Related references
Note: Only part of the references are listed.Cancer statistics, 2023
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2023)
Breast Cancer, Version 3.2022
William J. Gradishar et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2022)
Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial
Rupert Bartsch et al.
NATURE MEDICINE (2022)
Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup Analysis
Guy Jerusalem et al.
CANCER DISCOVERY (2022)
A pre-operative MRI-based brain metastasis risk-prediction model for triple-negative breast cancer
Xiaojie Cheng et al.
GLAND SURGERY (2021)
A nomogram for predicting brain metastasis in patients with de novo stage IV breast cancer
Ming-Shuai Sun et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
R. K. Murthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Risk factors for breast cancer brain metastases: a systematic review
Lola Koniali et al.
Oncotarget (2020)
Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial
Nancy U. Lin et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial
F. Montemurro et al.
ANNALS OF ONCOLOGY (2020)
Treatment response as predictor for brain metastasis in triple negative breast cancer: A score-based model
Prashant Gabani et al.
BREAST JOURNAL (2019)
TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases
Rachel A. Freedman et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort
Amelie Darlix et al.
BRITISH JOURNAL OF CANCER (2019)
Predicting Brain Metastasis in Breast Cancer Patients: Stage Versus Biology
Hamdy A. Azim et al.
CLINICAL BREAST CANCER (2018)
Molecular subtype predicts incidence and prognosis of brain metastasis from breast cancer in SEER database
Yi-Jun Kim et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Prediction of postoperative disease-free survival and brain metastasis for HER2-positive breast cancer patients treated with neoadjuvant chemotherapy plus trastuzumab using a machine learning algorithm
Masahiro Takada et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Novel immunohistochemistry-based signatures to predict metastatic site of triple-negative breast cancers
Sergey Klimov et al.
BRITISH JOURNAL OF CANCER (2017)
Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer The NEfERT-T Randomized Clinical Trial
Ahmad Awada et al.
JAMA ONCOLOGY (2016)
Predicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patients
Renata Duchnowska et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA
I. E. Krop et al.
ANNALS OF ONCOLOGY (2015)
Predictive factors of brain metastasis in patients with breast cancer
Jun Xue et al.
MEDICAL ONCOLOGY (2013)
Brain metastases after breast-conserving therapy and systemic therapy: incidence and characteristics by biologic subtype
Nils D. Arvold et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Incidence and time trends of brain metastases admissions among breast cancer patients in Sweden
G. Frisk et al.
BRITISH JOURNAL OF CANCER (2012)
EFFECT OF TUMOR SUBTYPE ON SURVIVAL AND THE GRADED PROGNOSTIC ASSESSMENT FOR PATIENTS WITH BREAST CANCER AND BRAIN METASTASES
Paul W. Sperduto et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Survival of breast cancer patients with meningeal carcinomatosis
H. Gauthier et al.
ANNALS OF ONCOLOGY (2010)
Brain metastases admissions in Sweden between 1987 and 2006
K. E. Smedby et al.
BRITISH JOURNAL OF CANCER (2009)
Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)
BC Pestalozzi et al.
ANNALS OF ONCOLOGY (2006)
Share Paper
